The anticoagulant properties of mast cell product, chondroitin sulphate E

This publication has 39 references indexed in Scilit:

• Lack of correlation between “in vitro” and “in vivo” antithrombotic activity of heparin fractions and related compounds. Heparan sulfate as an antithrombotic agent “in vivo”
  Thrombosis Research, 1985
• Isolation and characterization of glycosaminoglycans in human plasma.
  Journal of Clinical Investigation, 1985
• Purification and biological property of heparin cofactor II: Activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans
  Thrombosis Research, 1984
• Anticoagulant and antiheparin activities of a pentosan polysulphate
  Thrombosis Research, 1983
• Anticoagulant activity of dermatan polysulfates.
  The Tohoku Journal of Experimental Medicine, 1982
• Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences
  Biochemistry, 1980
• Comparison of the inhibition of thrombin by three plasma protease inhibitors
  Biochemistry, 1978
• Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin.
  The Journal of Experimental Medicine, 1978
• The anticoagulant effect of heparan sulfate and dermatan sulfate
  Thrombosis Research, 1976
• A novel dermatan polysulfate from hagfish skin, containing trisulfated disaccharide residues
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1972